D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
AMPH holding history
Amphastar Pharmaceuticals, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AMPH overviewAll 13F holders of AMPHFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −11,244−100.0% | Sold out | Holders |
| Q4 2024 | 11,244 | $417.5K | <0.1% | +11,244 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −21,651−100.0% | Sold out | Holders |
| Q1 2024 | 21,651 | $950.7K | <0.1% | −4,973−18.7% | Reduced | Holders |
| Q4 2023 | 26,624 | $1.65M | <0.1% | −205−0.8% | Reduced | Holders |
| Q3 2023 | 26,829 | $1.23M | <0.1% | −3,058−10.2% | Reduced | Holders |
| Q2 2023 | 29,887 | $1.72M | <0.1% | −15,187−33.7% | Reduced | Holders |
| Q1 2023 | 45,074 | $1.69M | <0.1% | −3,837−7.8% | Reduced | Holders |
| Q4 2022 | 48,911 | $1.37M | <0.1% | −179−0.4% | Reduced | Holders |
| Q3 2022 | 49,090 | $1.38M | <0.1% | −1,249−2.5% | Reduced | Holders |
| Q2 2022 | 50,339 | $1.75M | <0.1% | −795−1.6% | Reduced | Holders |
| Q1 2022 | 51,134 | $1.84M | <0.1% | +51,134 | New | Holders |